Detalles de la búsqueda
1.
Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational study.
J Antimicrob Chemother
; 78(8): 1929-1933, 2023 08 02.
Artículo
Inglés
| MEDLINE | ID: mdl-37303236
2.
Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance.
J Antimicrob Chemother
; 78(6): 1510-1521, 2023 06 01.
Artículo
Inglés
| MEDLINE | ID: mdl-37104815
3.
Is vaccine response to SARS-CoV-2 preserved after switching to anti-CD20 therapies in patients with multiple sclerosis or related disorders?
J Neurol Neurosurg Psychiatry
; 95(1): 19-28, 2023 Dec 14.
Artículo
Inglés
| MEDLINE | ID: mdl-37479463
4.
Kinetics of Archived M184V Mutation in Treatment-Experienced Virally Suppressed HIV-Infected Patients.
J Infect Dis
; 225(3): 502-509, 2022 02 01.
Artículo
Inglés
| MEDLINE | ID: mdl-34415048
5.
Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare Workers.
Clin Infect Dis
; 74(4): 707-710, 2022 03 01.
Artículo
Inglés
| MEDLINE | ID: mdl-34050731
6.
More HIV-1 RNA detected and quantified with the Cobas 6800 system in patients on antiretroviral therapy.
J Antimicrob Chemother
; 77(8): 2251-2256, 2022 07 28.
Artículo
Inglés
| MEDLINE | ID: mdl-35640662
7.
Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders.
J Neurol Neurosurg Psychiatry
; 93(1): 24-31, 2022 01.
Artículo
Inglés
| MEDLINE | ID: mdl-34341142
8.
No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments.
J Antimicrob Chemother
; 76(6): 1553-1557, 2021 05 12.
Artículo
Inglés
| MEDLINE | ID: mdl-33693680
9.
Presence of HIV-1 G-to-A mutations linked to APOBEC editing is more prevalent in non-B HIV-1 subtypes and is associated with lower HIV-1 reservoir.
J Antimicrob Chemother
; 76(8): 2148-2152, 2021 07 15.
Artículo
Inglés
| MEDLINE | ID: mdl-33930161
10.
Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients.
J Antimicrob Chemother
; 76(7): 1893-1897, 2021 06 18.
Artículo
Inglés
| MEDLINE | ID: mdl-33855355
11.
Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.
J Antimicrob Chemother
; 76(9): 2400-2406, 2021 08 12.
Artículo
Inglés
| MEDLINE | ID: mdl-34100068
12.
Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy.
J Antimicrob Chemother
; 75(4): 1026-1030, 2020 04 01.
Artículo
Inglés
| MEDLINE | ID: mdl-31976534
13.
Characterization of viral rebounds on dual etravirine/raltegravir maintenance therapy (ANRS-163 ETRAL trial).
J Antimicrob Chemother
; 75(7): 1943-1949, 2020 07 01.
Artículo
Inglés
| MEDLINE | ID: mdl-32259255
14.
Ultra-rapid selection of the N74D capsid inhibitor resistance mutation after 3â weeks on lenacapavir.
J Antimicrob Chemother
; 2024 Apr 17.
Artículo
Inglés
| MEDLINE | ID: mdl-38629483
15.
Prolonged replication of BA.1 and BA.2 Omicron lineages compared to Delta variant in nasopharyngeal samples from COVID-19 patients.
Infect Dis Now
; 53(1): 104629, 2023 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-36323397
16.
Intermittent doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/TDF) maintains a high level of viral suppression in virologically suppressed people living with HIV.
Infect Dis Now
; 53(7): 104736, 2023 Oct.
Artículo
Inglés
| MEDLINE | ID: mdl-37321402
17.
Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV.
J Pers Med
; 13(4)2023 Mar 27.
Artículo
Inglés
| MEDLINE | ID: mdl-37108969
18.
Long-term evolution of humoral immune response after SARS-CoV-2 infection.
Clin Microbiol Infect
; 28(7): 1027.e1-1027.e4, 2022 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-35307573
19.
Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study.
Lancet HIV
; 9(8): e544-e553, 2022 08.
Artículo
Inglés
| MEDLINE | ID: mdl-35905753
20.
SARS-CoV-2 infection in patients with primary central nervous system lymphoma.
J Neurol
; 268(9): 3072-3080, 2021 Sep.
Artículo
Inglés
| MEDLINE | ID: mdl-33387015